TFO
COGT icon

Tarbox Family Office’s Cogent Biosciences COGT Stock Holding History

Tarbox Family Office’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-278
Closed -$2K – 1127
2021
Q3 		$2K Hold
278
– – ﹤0.01% 903
2021
Q2 		$2K Buy
+278
New +$2.35K ﹤0.01% 909

Other funds holding COGT

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Tarbox Family Office's COGT Position: Q4 2021 in Review

Tarbox Family Office sold out of Cogent Biosciences (COGT) in Q4 2021, closing a stake of 278 shares — an estimated $2K sold.

Tarbox Family Office first reported a position in COGT in Q2 2021 and held it in 2 quarters. The position peaked at $2K in Q3 2021. 82 funds tracked by Wall St. Rank hold COGT as of Q4 2021.

  • Tarbox Family Office reported no remaining Cogent Biosciences position as of Q4 2021 after selling out during the quarter.
  • Tarbox Family Office sold 278 Cogent Biosciences shares in Q4 2021, an estimated $2K.
  • Tarbox Family Office first reported a position in Cogent Biosciences in Q2 2021 and held it in 2 quarters.
  • Tarbox Family Office's Cogent Biosciences position peaked at $2K in Q3 2021.
  • 82 funds tracked by Wall St. Rank held Cogent Biosciences as of Q4 2021.

Based on Tarbox Family Office's 13F filing for Q4 2021, filed 6 Jan 2022.